DAG1 and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan: In several forms of CMD, abnormal glycosylation of α-dystroglycan (α-DG) results in conditions collectively known as dystroglycanopathies, which are associated with central nervous system involvement.